Schott strengthens South American pharma glass footprint

As part of its global growth strategy, Schott is investing BRL 50 million in pharmaceutical tubing production in Rio de Janeiro, Brazil in the next two years. The investment covers the latest update of the company’s perfeXion process – a 100% on-line inspection system, which examines every single tube – as well as implementing state-of-the-art melting technology. This follows an earlier modernisation project, which has already raised investments in excess of BRL 80 million during the last five years.

“In line with our zero defect approach, we already established a new era in quality processing for pharmaceutical tubing with perfeXion” explained Joerg Wagner, Technical Director of SCHOTT Brazil Division Vitrofarma. “Now, the investment allows us to further optimise the machinery to continue setting standards in the pharma glass industry."

The investment also features the implementation of advanced production technology in all glass melting furnaces. This enables the company to manufacture a higher quality product and contribute to the environment by reducing fossil fuel consumption and the emission of greenhouse gases.